Lenalidomide plus dexamethasone (Rev/Dex) in newly diagnosed myeloma: Response to therapy, time to progression, and survival.

被引：0
|
作者：
Lacy, Martha
Gertz, Morie
Dispenzieri, Angela
Hayman, Suzanne
Geyer, Susan
Zeldenrust, Steven
Kumar, Shaji
Greipp, Philip
Fonseca, Rafael
Lust, John
Russell, Stephen
Kyle, Robert
Witzig, Thomas
Bergsagel, Leif
Rajkumar, S. Vincent
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin Arizona, Scottsdale, AZ USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
798
引用
收藏
页码：239A / 239A
页数：1
相关论文
共 50 条
  • [1] Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma
    Rajkumar, SV
    Hayman, SR
    Lacy, MQ
    Dispenzieri, A
    Geyer, SM
    Kabat, B
    Zeldenrust, SR
    Kumar, S
    Greipp, PR
    Fonseca, R
    Lust, JA
    Russell, SJ
    Kyle, RA
    Witzig, TE
    Gertz, MA
    [J]. BLOOD, 2005, 106 (13) : 4050 - 4053
  • [2] Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma.
    Rajkumar, SV
    Hayman, S
    Lacy, MQ
    Dispenzieri, A
    Geyer, SM
    Kabat, B
    Zeldenrust, SR
    Kumar, S
    Greipp, PR
    Fonseca, R
    Lust, JA
    Russell, SJ
    Kyle, RA
    Witzig, TE
    Gertz, MA
    [J]. BLOOD, 2005, 106 (11) : 230A - 231A
  • [3] Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma
    Lacy, Martha Q.
    Gertz, Morie A.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Geyer, Susan
    Kabat, Brian
    Zeldenrust, Steven R.
    Kumar, Shajiku
    Greipp, Philip R.
    Fonseca, Rafael
    Lust, John A.
    Russell, Stephen J.
    Kyle, Robert A.
    Witzig, Thomas E.
    Bergsagel, P. Leif
    Stewart, A. Keith
    Rajkumar, S. Vincent
    [J]. MAYO CLINIC PROCEEDINGS, 2007, 82 (10) : 1179 - 1184
  • [4] Combination therapy with CC-5013 (Lenalidomide; Revlimid™) plus dexamethasone (Rev/Dex) for newly diagnosed myeloma (MM).
    Rajkumar, SV
    Hayman, SR
    Lacy, MQ
    Dispenzieri, A
    Hoering, A
    Geyer, SM
    Zeldenrust, SR
    Greipp, PR
    Fonseca, R
    Lust, JA
    Russell, SJ
    Kyle, RA
    Witzig, TE
    Gertz, MA
    [J]. BLOOD, 2004, 104 (11) : 98A - 98A
  • [5] Lenalidomide plus dexamethasone effective in newly diagnosed myeloma
    Kate Matthews
    [J]. Nature Clinical Practice Oncology, 2006, 3 (3): : 116 - 117
  • [6] Combination therapy with thalidomide plus dexamethasone (THAL/DEX) for newly diagnosed myeloma (MM).
    Rajkumar, SV
    Hayman, SR
    Gertz, MA
    Dispenzieri, A
    Lacy, M
    Greipp, PR
    Geyer, S
    Itturia, N
    Fonseca, R
    Lust, JA
    Kyle, R
    Witzig, TE
    [J]. BLOOD, 2001, 98 (11) : 849A - 849A
  • [7] Thalidomide, Intravenous Cyclophosphamide and Dexamethasone (ThaCyDex) in Newly Diagnosed Multiple Myeloma: Response to Therapy, Time to Progression and Survival
    Jezael Martinez-Rueda, Armando
    Maria Armillas-Canseco, Flor
    Olivas-Martinez, Antonio
    Martinez-Banos, Deborah
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S239 - S239
  • [8] Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma
    Jasielec, Jagoda K.
    Kubicki, Tadeusz
    Raje, Noopur
    Vij, Ravi
    Reece, Donna
    Berdeja, Jesus
    Derman, Benjamin A.
    Rosenbaum, Cara A.
    Richardson, Paul
    Gurbuxani, Sandeep
    Major, Sarah
    Wolfe, Brittany
    Stefka, Andrew T.
    Stephens, Leonor
    Tinari, Kathryn M.
    Hycner, Tyler
    Rojek, Alexandra E.
    Dytfeld, Dominik
    Griffith, Kent A.
    Zimmerman, Todd M.
    Jakubowiak, Andrzej J.
    [J]. BLOOD, 2020, 136 (22) : 2513 - 2523
  • [9] Induction therapy with high-dose dex alone in newly diagnosed myeloma patients produces a 57% partial response and is predictive of progression free survival.
    Irvine, David A.
    Barnett, Michael J.
    Brinkman, Ryan
    Forrest, Donna L.
    Hogge, Donna E.
    Lavoie, Julve
    Lei, Linda
    Nantel, Stephen H.
    Nevill, Thomas J.
    Nitta, Janet
    Shepherd, John
    Song, Kevin
    Toze, Cynthia
    Sutherland, Heather
    [J]. BLOOD, 2006, 108 (11) : 883A - 883A
  • [10] Daratumumab Plus Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
    Jakubowiak, Andrzej
    Usmani, Saad Z.
    Krishnan, Amrita
    Lonial, Sagar
    Comenzo, Raymond L.
    Wang, Jianping
    de Boer, Carla
    Deraedt, William
    Weiss, Brendan M.
    Schecter, Jordan M.
    Chari, Ajai
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (10): : 701 - 710
12345